We use cookies to enhance your experience. By continuing to browse this site you agree to our use of cookies. More info.
In a recent study posted to the medRxiv* preprint server, researchers assessed the impact of coronavirus disease 2019 (COVID-19) on cerebral blood flow in infected patients.
Symptoms including fatigue and brain fog have been reported by patients even after the course of a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The long-term effects of SARS-CoV-2 infection on the brain, however, are unknown.
Study: Decreased cerebral blood flow in non-hospitalized adults who self-isolated due to COVID-19. Image Credit: DOERS / Shutterstock
In the present study, researchers performed arterial spin labeling (ASL) magnetic resonance imaging (MRI) to investigate the effect of COVID-19 on the cerebral blood flow (CBF) in non-hospitalized COVID-19-recovered adults.
The team enrolled participants aged between 20 and 75 from May 2020 to September 2021 as part of the NeuroCOVID-19 protocol. The eligible participants were positive for SARS-CoV-2 via a real-time reverse transcription-polymerase chain reaction (rtRT-PCR) test performed on an oropharyngeal and/or nasopharyngeal swab. The participants were subsequently classified into two groups: (1) the COVID-19 group, including individuals who previously self-isolated following a COVID-19 diagnosis, and (2) the control group, including individuals who tested negative for COVID-19 but reported flu-like symptoms.
The primary outcome of the study included the measurement of ASL-derived CBF. The secondary outcomes were estimated using: (1) a questionnaire regarding flu-like symptoms answered by patients; (2) the cognition and emotion batteries from the National Institutes of Health (NIH) toolbox; and (3) the University of Pennsylvania smell identification test (UPSIT).
Patients were asked to complete a questionnaire in which they indicated the symptoms they were experiencing currently, had experienced previously, or if they had never experienced any flu-like symptoms including sore throat, cough, fever, fatigue, shortness of breath, smell/taste changes, and/or gastrointestinal symptoms.
The cognition battery from the NIH toolbox, a computerized assessment developed to measure the full spectrum of emotional health, generated two age-corrected standard scores of crystallized and fluid cognition, while the emotion battery generated three T-scores representing social satisfaction, negative affect, and well-being. In addition, the UPSIT resulted in scores that evaluated olfactory dysfunction.
As part of sensitivity analyses, the team conducted comparisons between the COVID-19 and the control group. The exploratory analysis assessed whether individuals who belonged to the COVID-19 group and reported fatigue as a current symptom displayed any CBF differences when compared to COVID-19 group individuals who reported previous experience of fatigue or no fatigue at all.
At the time of enrollment, 50 participants, including 39 belonging to the COVID-19 cohort and 11 belonging to the control cohort, were eligible for the study. The team screened COVID-19 group participants 116.5 ± 62.6 days after testing COVID-19 positive.
a) Timing of PCR test (left marker) and assessment (right marker) for COVID-19 (orange squares) participants and controls (green circle). Confirmed cases in Ontario are shown in grey. b) Number of days between PCR test and assessment. The black dotted line indicates 28 days, an established threshold beyond which symptoms can be considered part of the post- COVID-19 condition. c) Proportion of participants who self-reported flu-like symptoms. Faint bars indicate participants whose symptoms had resolved by the time of the assessment while dark bars indicate participants with on-going symptoms. d) Representative and group-averaged CBF maps from both groups.
The study results showed that among the COVID-19 and control participants, 28.2% and 36.4% reported fatigue, and 20.5% and 27.3% had shortness of breath, respectively.
Interestingly, 92.3% of the COVID-19 and 72.7% of the control individuals reported fatigue between the time points of the PCR test and assessment. Moreover, smell/ taste alterations were experienced by more COVID-19 group participants than the control persons. Notably, there were no significant differences between the two groups concerning the cognitive and emotion tests, or the UPSIT scores.
In comparison to the control group, the COVID-19 group displayed significantly reduced CBF in voxel clusters that encompassed the orbitofrontal cortex, thalamus, and the regions such as the caudate, nucleus accumbens, pallidum, and putamen of the basal ganglia. Also, there were no voxel clusters in the COVID-19 group with CBF higher than in the controls.
With partial volume correction, sensitivity analysis showed smaller clusters than those observed in the primary analysis. Again, CBF levels higher than those in the control group were observed in none of the COVID-19 group clusters. On the other hand, the exploratory analyses showed CBF differences among individuals from the COVID-19 group who did and did not report ongoing fatigue. Ongoing fatigue was defined to have increased CBF in the superior occipital and parietal regions with lower CBF levels in the inferior occipital regions (lingual gyrus, occipital fusiform gyrus, intracalcarine cortex, precuneous cortex).
Study results showed a decrease in CBF in those recovering from COVID-19 as compared to controls. The CBF differences with respect to ongoing fatigue as reported by the COVID-19 group suggested the role of CBF in heterogeneous symptoms related to the post-COVID-19 condition. As a whole, the study concluded that post-COVID-19 symptoms are associated with long-term changes in brain physiology and function.
medRxiv publishes preliminary scientific reports that are not peer-reviewed and, therefore, should not be regarded as conclusive, guide clinical practice/health-related behavior, or treated as established information.
Posted in: Men's Health News | Medical Research News | Medical Condition News | Women's Health News | Disease/Infection News
Tags: Blood, Brain, Brain Fog, Coronavirus, Coronavirus Disease COVID-19, Cortex, Cough, Fatigue, Fever, Flu, Imaging, Magnetic Resonance Imaging, Nasopharyngeal, Neurology, Physiology, Polymerase, Polymerase Chain Reaction, Putamen, Respiratory, SARS, SARS-CoV-2, Severe Acute Respiratory, Severe Acute Respiratory Syndrome, Sore Throat, Syndrome, Thalamus, Throat, Transcription
Bhavana Kunkalikar is a medical writer based in Goa, India. Her academic background is in Pharmaceutical sciences and she holds a Bachelor's degree in Pharmacy. Her educational background allowed her to foster an interest in anatomical and physiological sciences. Her college project work based on ‘The manifestations and causes of sickle cell anemia’ formed the stepping stone to a life-long fascination with human pathophysiology.
Please use one of the following formats to cite this article in your essay, paper or report:
Kunkalikar, Bhavana. (2022, May 10). COVID-19 and cerebral blood flow. News-Medical. Retrieved on May 21, 2022 from https://www.news-medical.net/news/20220510/COVID-19-and-cerebral-blood-flow.aspx.
Kunkalikar, Bhavana. "COVID-19 and cerebral blood flow". News-Medical. 21 May 2022. <https://www.news-medical.net/news/20220510/COVID-19-and-cerebral-blood-flow.aspx>.
Kunkalikar, Bhavana. "COVID-19 and cerebral blood flow". News-Medical. https://www.news-medical.net/news/20220510/COVID-19-and-cerebral-blood-flow.aspx. (accessed May 21, 2022).
Kunkalikar, Bhavana. 2022. COVID-19 and cerebral blood flow. News-Medical, viewed 21 May 2022, https://www.news-medical.net/news/20220510/COVID-19-and-cerebral-blood-flow.aspx.
In this interview, we speak to Martin Mangold, an applications specialist at BMG LABTECH, about their microplate readers and the essential role they play within life sciences research.
In this interview, News-Medical speaks to Thanh T. Nguyen, a project manager at Innocore Pharmaceuticals, about the mechanisms behind long-acting injectables.
In this interview, we speak to Dr. Damini Dey from Cedars-Sinai Medical Center about their latest research that involved using AI to predict heart attacks.
News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.
This site complies with the HONcode standard for trustworthy health information: verify here.
News-Medical.net - An AZoNetwork Site
Owned and operated by AZoNetwork, © 2000-2022